Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

CRMD CorMedix Inc.
$8.20 2.50% +0.20
Notify me if price changes either direction
Interactive Brokers Logotype

Buy CRMD stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades

CorMedix Inc. (CRMD)

Loading

Key Stats

Market cap. 639.1M
Enterprise value 509.6M
Trailing PE 3.914634
Forward PE 22.92857
PEG Ratio 0.283810965
Enterprise to EBITDA 1.941
Enterprise to revenue 1.103
Price to book MRQ 1.352604
Price to sales TTM 1.3531737

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-06-30
Revenue (TTM) 462.2M
EBITDA 266.6M
Diluted EPS TTM 2.05
Total Cash (MRQ) 256.7M
Current ratio (MRQ) 2.564
Operating Cash Flow (TTM) 253.9M

CRMD trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent CRMD News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.